The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at unprecedented speed to develop vaccines- treatments- and tests
This article covers the last four months of deal data provided by Chris Dokomajilar of DealForma
Our team at PharmaShots…
